advertisement

Topcon

Cheng S 37

Showing records 1 to 25 | Display only abstracts from Cheng S in IGR 21-4

107697 Activation of retinal glial cells contributes to the degeneration of ganglion cells in experimental glaucoma
Miao Y; Zhao GL; Cheng S; Cheng S; Wang Z; Yang XL
Progress in Retinal and Eye Research 2023; 93: 101169 (IGR: 23-4)


106426 EphA4/ephrinA3 reverse signaling mediated downregulation of glutamate transporter GLAST in Müller cells in an experimental glaucoma model
Zhou ZX
GLIA 2023; 71: 720-741 (IGR: 23-3)


105986 Case report: Congenital mitral and tricuspid valve insufficiency in a patient with Axenfeld-Rieger syndrome
Feng J
Frontiers in cardiovascular medicine 2022; 9: 977432 (IGR: 23-3)


106426 EphA4/ephrinA3 reverse signaling mediated downregulation of glutamate transporter GLAST in Müller cells in an experimental glaucoma model
Xu LJ
GLIA 2023; 71: 720-741 (IGR: 23-3)


105986 Case report: Congenital mitral and tricuspid valve insufficiency in a patient with Axenfeld-Rieger syndrome
Wang Y; Cheng S; Cheng S
Frontiers in cardiovascular medicine 2022; 9: 977432 (IGR: 23-3)


106426 EphA4/ephrinA3 reverse signaling mediated downregulation of glutamate transporter GLAST in Müller cells in an experimental glaucoma model
Wang HN; Cheng S; Cheng S
GLIA 2023; 71: 720-741 (IGR: 23-3)


105986 Case report: Congenital mitral and tricuspid valve insufficiency in a patient with Axenfeld-Rieger syndrome
Liu Z
Frontiers in cardiovascular medicine 2022; 9: 977432 (IGR: 23-3)


106426 EphA4/ephrinA3 reverse signaling mediated downregulation of glutamate transporter GLAST in Müller cells in an experimental glaucoma model
Li F
GLIA 2023; 71: 720-741 (IGR: 23-3)


105986 Case report: Congenital mitral and tricuspid valve insufficiency in a patient with Axenfeld-Rieger syndrome
Lan L; Miao Q
Frontiers in cardiovascular medicine 2022; 9: 977432 (IGR: 23-3)


106426 EphA4/ephrinA3 reverse signaling mediated downregulation of glutamate transporter GLAST in Müller cells in an experimental glaucoma model
Miao Y; Lei B
GLIA 2023; 71: 720-741 (IGR: 23-3)


105986 Case report: Congenital mitral and tricuspid valve insufficiency in a patient with Axenfeld-Rieger syndrome
Zhang C
Frontiers in cardiovascular medicine 2022; 9: 977432 (IGR: 23-3)


106426 EphA4/ephrinA3 reverse signaling mediated downregulation of glutamate transporter GLAST in Müller cells in an experimental glaucoma model
Gao F; Wang Z
GLIA 2023; 71: 720-741 (IGR: 23-3)


100555 Habitual Coffee Consumption Increases Risk of Primary Open-Angle Glaucoma: A Mendelian Randomization Study
Li X; Cheng S; Cheng S; Cheng J; Wang M; Zhong Y; Yu AY
Ophthalmology 2022; 129: 1014-1021 (IGR: 23-1)


96230 Soluble tumor necrosis factor-alpha-induced hyperexcitability contributes to retinal ganglion cell apoptosis by enhancing Nav1.6 in experimental glaucoma
Cheng S; Cheng S
Journal of Neuroinflammation 2021; 18: 182 (IGR: 22-3)


95770 Design and Methodology of a Multi-Centre Clinical Trial of Low Dose Laser Cycloplasty for the Treatment of Malignant Glaucoma in China
Lin H; Wang J
Ophthalmic Epidemiology 2021; 0: 1-8 (IGR: 22-3)


96230 Soluble tumor necrosis factor-alpha-induced hyperexcitability contributes to retinal ganglion cell apoptosis by enhancing Nav1.6 in experimental glaucoma
Wang HN
Journal of Neuroinflammation 2021; 18: 182 (IGR: 22-3)


95770 Design and Methodology of a Multi-Centre Clinical Trial of Low Dose Laser Cycloplasty for the Treatment of Malignant Glaucoma in China
Fan S
Ophthalmic Epidemiology 2021; 0: 1-8 (IGR: 22-3)


96230 Soluble tumor necrosis factor-alpha-induced hyperexcitability contributes to retinal ganglion cell apoptosis by enhancing Nav1.6 in experimental glaucoma
Xu LJ; Li F
Journal of Neuroinflammation 2021; 18: 182 (IGR: 22-3)


95770 Design and Methodology of a Multi-Centre Clinical Trial of Low Dose Laser Cycloplasty for the Treatment of Malignant Glaucoma in China
Wu Z
Ophthalmic Epidemiology 2021; 0: 1-8 (IGR: 22-3)


96230 Soluble tumor necrosis factor-alpha-induced hyperexcitability contributes to retinal ganglion cell apoptosis by enhancing Nav1.6 in experimental glaucoma
Miao Y
Journal of Neuroinflammation 2021; 18: 182 (IGR: 22-3)


95770 Design and Methodology of a Multi-Centre Clinical Trial of Low Dose Laser Cycloplasty for the Treatment of Malignant Glaucoma in China
Xu X; Cai Q
Ophthalmic Epidemiology 2021; 0: 1-8 (IGR: 22-3)


96230 Soluble tumor necrosis factor-alpha-induced hyperexcitability contributes to retinal ganglion cell apoptosis by enhancing Nav1.6 in experimental glaucoma
Lei B; Sun X
Journal of Neuroinflammation 2021; 18: 182 (IGR: 22-3)


95770 Design and Methodology of a Multi-Centre Clinical Trial of Low Dose Laser Cycloplasty for the Treatment of Malignant Glaucoma in China
Zhao L
Ophthalmic Epidemiology 2021; 0: 1-8 (IGR: 22-3)


96230 Soluble tumor necrosis factor-alpha-induced hyperexcitability contributes to retinal ganglion cell apoptosis by enhancing Nav1.6 in experimental glaucoma
Wang Z
Journal of Neuroinflammation 2021; 18: 182 (IGR: 22-3)


95770 Design and Methodology of a Multi-Centre Clinical Trial of Low Dose Laser Cycloplasty for the Treatment of Malignant Glaucoma in China
Cheng S; Cheng S; Zhang S; Liang Y;
Ophthalmic Epidemiology 2021; 0: 1-8 (IGR: 22-3)


Issue 21-4

Change Issue


advertisement

Oculus